To treat infected with a coronavirus need a new vaccine

Testing of mRNA vaccine-1273 must begin in April. For this will be invited 20-25 healthy volunteers.

American biotechnology company Moderna introduced the vaccine mRNA-1273 from coronavirus COVID-19, which is scheduled to be tested on humans. This is stated in the message published on the website of the company on Monday, February 24.

It is noted that the first batch of vials of vaccine were sent to the national Institute of allergic and infectious diseases (NIAID) to test on humans.

The vaccine was created in record time – in just 42 days from the moment of definition of the genome of the coronavirus. Worked on it about a hundred employees.

As said in comments to The Wall Street Journal, the Director of NIAID, Anthony Fosi, vaccine trials to begin in April. For this will be invited 20-25 healthy volunteers, they administered two doses of vaccine to assess its safety and the formation of the immune response necessary to protect against the virus.

It is expected that the first test results may appear in July or August. If they are successful, widely available vaccine will appear within a few months after that.

According to the latest data in China, the number of confirmed cases of infection with coronavirus reached 77658 man 2663 man died. New foci of infection in recent days, became Italy, South Korea and Iran.

News from the Reporter.net Telegram. Subscribe to our channel https://t.me/korrespondentnet

Coronavirus

The number of victims of coronavirus in China exceeded 2700

Coronavirus: the number of recovered exceeded 28 thousand

Outside of China, a coronavirus infected nearly 2,500 people

The first case of infection with coronavirus identified in Germany

Everyone entering the U.S. will be to measure the temperature